Gamma tACS in Attention-Deficit/Hyperactivity Disorder

NAEnrolling by invitationINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2027

Conditions
Attention Deficit Disorder With Hyperactivity (ADHD)
Interventions
DEVICE

Application tACS- 80 Hz

In this study, a single 20-minute session of tACS will be administered over the bilateral dorsolateral prefrontal cortex (DLPFC) at various gamma frequencies (80 Hz).The anodal surface electrode will be placed over the left DLPFC (F3 according to the 10-20 system), and the cathodal electrode over the right DLPFC (F4).

DEVICE

Application tACS -40 Hz

In this study, a single 20-minute session of tACS will be administered over the bilateral dorsolateral prefrontal cortex (DLPFC) at gamma frequencies (40 Hz). The anodal surface electrode will be placed over the left DLPFC (F3 according to the 10-20 system), and the cathodal electrode over the right DLPFC (F4).

DEVICE

Application TACS - (6-80 Hz)

In this study, a single 20-minute session of tACS will be administered over the bilateral dorsolateral prefrontal cortex (DLPFC) at theta- gamma coupling frequencies ( 6-80 Hz). The anodal surface electrode will be placed over the left DLPFC (F3 according to the 10-20 system), and the cathodal electrode over the right DLPFC (F4).

DEVICE

Application TACS- Individual Gamma Hz

In this study, a single 20-minute session of tACS will be administered over the bilateral dorsolateral prefrontal cortex (DLPFC) at individual gamma frequencies . The anodal surface electrode will be placed over the left DLPFC (F3 according to the 10-20 system), and the cathodal electrode over the right DLPFC (F4).

DEVICE

Application TACS- Sham

In this study, a single 20-min tACS session will be applied over the bilateral dorsolateral prefrontal cortex (DLPFC) in a sham application. The anodal surface electrode will be placed over the left DLPFC (F3 of the 10-20 system) and the cathodal electrode will be placed over the right DLPFC (F4).

Trial Locations (1)

Unknown

Medipol University Istanbul, Istanbul

All Listed Sponsors
lead

Medipol University

OTHER

NCT07145593 - Gamma tACS in Attention-Deficit/Hyperactivity Disorder | Biotech Hunter | Biotech Hunter